Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Plus two. That's the 2027 outlook for lab hiring budgets in Lab Manager's Fall 2026 Purchasing Trends Survey. It was +10 in the previous wave, and no other category fell further. At the top of the same list are raw materials at +31 and consumables at +30. Both got stronger.

The survey, written up by Trevor J Henderson on November 11, asked respondents from clinical, pharma, academic, environmental and industrial labs how 12 budget categories will move over the next year. Each line gets a net score: the share of labs expecting an increase minus the share expecting a cut. On hiring, almost a quarter of labs expect their budget to shrink.

For a lab manager about to file a request, this tells you how the conversation with finance will go. Supplies are the easy ask. A new person is the hard one.

Rising prices behind the supply lines

Labs expect the lines that keep the bench running to grow fastest, and price explains much of that. Respondents told Lab Manager costs were rising on almost everything they buy, from reagents to shipping. The publication's reading is blunt: a lab whose consumables budget stays flat is probably buying less, not holding steady.

The middle of the chart deserves a look too. Training and education rose to +27, which Lab Manager reads as short-staffed labs putting money into the people they already have. Projects (+22) and lab technology (+19) are still healthy but cooled slightly. Construction (+17) and facility modernization (+14) both went up, which fits the move toward planned capital work covered below.

Then there's what finance is focused on. Ninety-four percent of labs said cost reduction is a significant concern when they buy, and the share who strongly agree rose from 51% to 58%. So every request will be read by people hunting for savings. A supply increase that separates price from volume answers their first question before they ask it. If sample counts held steady and supplier prices climbed, the request can say so in one table, and it reads as the cost of doing the same work.

What a new hire actually costs

There's a reason hiring sits near zero, and it shows up in real lab budgets. Benjamin A. Garcia, professor and head of biochemistry and molecular biophysics at Washington University in St. Louis, published his own numbers in ASBMB Today in October. He estimates a graduate student costs about $46,000 a year at his institution, and a postdoc $80,000 to $100,000 once fringe benefits are included. For a lab of 10 to 12 people, he puts personnel alone at roughly $550,000 to $850,000 a year, inside a direct annual cost that can top $1 million before any major instrument purchase.

His point for trainees applies just as well to a budget committee. A reagent order is a single purchase. A hire is a cost that comes back every year. A $100,000 postdoc becomes a $100,000 line in next year's budget too, and the year after.

Pay planning across life sciences makes that line grow over time. Pave and Alpine Rewards surveyed 251 companies and found life sciences firms planning a median 3.5% merit budget for 2027, with the 25th percentile also at 3.5%. Promotion and adjustment pools are getting smaller, falling from 1.8% in 2026 to 1.5% planned for 2027. That data covers companies, not academic or municipal labs, but it suggests the cost of keeping existing staff will keep going up whether or not a new position is approved.

Lab Manager's advice is to frame a new position around throughput, turnaround and risk rather than workload alone. Two other scores in the survey back that up. Outsourcing slipped to −2, which suggests more labs plan to keep work in-house, while hiring stays nearly flat. Training and education also improved, to +27, and the survey notes that labs short on staff are investing in the people they have. For labs keeping more work in-house with roughly the same staff, a staffing request built only on how busy people are could struggle.

Fewer rush orders, more 12-month plans

The timing questions show a quieter change. Fewer labs need everyday supplies in a hurry, while more have bigger purchases on their 12-month list.

Furniture isn't alone. More labs now plan to buy vacuum pumps, titrators, pH meters, spectroscopy, mass spectrometry and informatics (LIMS and ELN). Centrifuges and autoclaves moved in the opposite direction, with fewer labs expecting to replace them. Everyday supplies still lead the overall list: within 12 months, 70% of labs plan to buy chemicals, 69% PPE and 61% pipettes.

There's a real caveat on the timing data, and Lab Manager raises it. The previous wave ran mostly in December and January, when many budget years start. This one ran in September and October. A lab asked at the start of its fiscal year will likely report more immediate orders, so some of the drop in six-month urgency is probably just the calendar. The survey's authors say the direction holds anyway. The safer reading is that the rise in 12-month capital plans is the stronger signal, since it moves the same way as the construction and modernization scores.

Turning the benchmarks into a request

Lab Manager walks through an illustrative case: a municipal environmental testing lab with 11 staff, running drinking water and wastewater analyses under state accreditation, with a fiscal year starting July 1 and six weeks to file. In past years its request was a single wish list, most of it got cut, and urgent buys came back mid-year as emergency requisitions.

The rebuilt request split spending into three groups. Run costs covered reagents, standards, consumables and PPE, with price separated from volume. Replacement covered an ICP-MS nearing the end of vendor support and sample-prep casework that no longer met chemical-resistance needs. Growth was a LIMS module to automate state reporting and cut weekly manual data entry. Each item was then scheduled by quarter:

1. Q1 (Jul, Sep): Restock PPE and sign annual reagent and consumables contracts, locking in pricing early so the lab avoids emergency orders mid-year
2. Q2 (Oct, Dec): Complete the LIMS reporting module and its validation ahead of the spring accreditation audit
3. Q3 (Jan, Mar): Replace sample-prep casework during a lower-volume stretch; because the lead time runs 10, 12 weeks, the order goes in during Q2
4. Q4 (Apr, Jun): Replace the ICP-MS under a service contract, with funding in place before vendor support for the old unit ends in June

The ICP-MS line shows the approach most clearly. Instead of asking for a new instrument, the request priced the risk: what it would cost in outsourced testing and missed deadlines if an unsupported instrument failed during compliance-monitoring season. That's the same framing Lab Manager recommends for a new position, and it suggests the strongest 2027 requests will treat people and instruments the same way, as costs set against specific risks the lab can name.

For other labs, the lesson is about timing. Budget season starts long before the request is due, which suggests building a quarter plan like this one early, not in the last weeks before filing.

The score to watch next time

Labs heading into 2027 expect their reagent budgets to grow and their headcount budgets to stall: consumables carry a net outlook of +30, hiring just +2. The next survey wave will show whether that's a pause or a pattern. If hiring stays near zero while training holds in the high 20s and informatics plans keep rising, labs will have decided to get more out of the teams they already have, and the LIMS and capital lines are where that choice gets paid for.